MedTrace Logo

The Onset Time of Rocuronium in Emergency and Elective Surgery

NCT02634255 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2015-12-18

No results posted yet for this study

Summary

Rocuronium, a nondepolarizing neuromuscular blocking agent, is used in general anesthesia to provide conditions for endotracheal intubating. Recommended dose is 0,6 mg/kg and 90 seconds after intravenous injection, patients can be intubated.

Anxiety levels may vary in patients undergoing emergency and elective surgery. Patients undergoing emergency surgery may display exaggerated laryngoscopic responses. The purpose of this study is to investigate the effect of patient anxiety levels on the onset time of rocuronium in terms of anxiety scores and train of four (TOF) 0.1 times.

Conditions

  • Inguinal Hernia
  • Acute Appendicitis

Interventions

DRUG

Rocuronium elective surgery

Rocuronium onset time in patients undergoing inguinal herniorrhaphy

DRUG

Rocuronium emergency surgery

Rocuronium onset time in patients undergoing appendectomy

DRUG

Propofol

DRUG

Fentanyl

OTHER

Ringer Lactate

DEVICE

Acceleromyography device

Sponsors & Collaborators

  • Diskapi Yildirim Beyazit Education and Research Hospital

    lead OTHER_GOV

Principal Investigators

  • Murat Sayın, Assoc Prof · Diskapi Yildirim Beyazit Education and Research Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-12-31
Primary Completion
2016-05-31
Completion
2016-07-31

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02634255 on ClinicalTrials.gov